To determine whether the expression of RANBP10 was a prognostic factor for GBM, we performed the immunohistochemistry assays in 12 paired samples and the results indicated that RANBP10 expression was higher in GBM than the adjacent normal brain tissues (Fig. 1A). The gene discussed is RANBP10; the disease is glioblastoma.